MEI Pharma, Inc.
NASDAQ Capital MarketTotal Valuation
MEI Pharma, Inc. carries a market capitalization of 20.45M, placing it among publicly traded companies globally. Its enterprise value stands at -1.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.45M |
| Enterprise Value | -1.55M |
Share Statistics
MEI Pharma, Inc. currently has 6.66M shares outstanding.
| Shares Outstanding | 6.66M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.04 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | -0.79 |
| P/OCF Ratio | -0.79 |
Financial Position
MEI Pharma, Inc. maintains a current ratio of 13.50, meaning it holds 13.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 13.50 |
| Quick Ratio | 13.30 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -53.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
MEI Pharma, Inc.'s stock has gained approximately 13.7037% over the past 52 weeks. The 50-day moving average sits at 4.55, while the 200-day moving average is 2.94.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.7037% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 2.94 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -17.09M, while operating income came in at -17.45M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -17.45M |
| Pretax Income | -15.94M |
| Net Income | -15.94M |
| EBITDA | -17.09M |
| EBIT | -17.45M |
| Earnings Per Share (EPS) | -2.39 |
Balance Sheet
Total book value stands at -404.16M, with working capital of 16.93M providing operational flexibility.
| Cash & Cash Equivalents | 18.01M |
| Total Debt | N/A |
| Net Debt | -18.01M |
| Equity (Book Value) | -404.16M |
| Book Value Per Share | -60.66 |
| Working Capital | 16.93M |
Cash Flow
MEI Pharma, Inc. produced -20.84M in operating cash flow over the past twelve months.
| Operating Cash Flow | -20.84M |
| Capital Expenditures | N/A |
| Free Cash Flow | -20.84M |
| FCF Per Share | -3.13 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -126.65 |
Stock Splits
MEI Pharma, Inc.'s most recent stock split took place on April 17, 2023 with a 20:1 split ratio.
| Last Split Date | 4/17/2023 |
| Split Ratio | 20:1 |
Scores
MEI Pharma, Inc. posts an Altman Z-Score of -25.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -25.69 |